Skip to main content
. 2021 Sep 9;6(3):e25751. doi: 10.2196/25751

Table 4.

Change in HbA1ca from baseline to 12-month follow-up by intervention completion.

Participants Baseline HbA1c (mmol/mol), mean (SD) 12-month HbA1c (mmol/mol) mean (SD) 12-month HbA1c change (mmol/mol), mean (SD) 12-month HbA1c change (%), mean (SD) P value
Pooled (all participants)

All participants (N=45) 56.68 (16.95) 52.80 (14.68) 3.89 (4.32) 6.28 (5.49) <.001

Completers (n=32) 58.8 (18.00) 54.0 (15.7) 4.78 (4.6) 7.62 (5.40) <.001

Noncompleters (n=13) 51.5 (13.23) 49.8 (12.01) 1.69 (2.53) 3.3 (4.31) .03
Type 2 diabetes (HbA1c ≥48 mmol/mol)

All participants (n=18) 73.35 (15.84) 67.20 (13.59) 6.19 (5.75) 7.96 (6.67) <.001

Completers (n=14) 75.7 (14.9) 68.7 (12.8) 7.01 (6.06) 8.81 (6.77) <.001

Noncompleters (n=4) 65.1 (18.41) 61.8 (17.10) 3.13 (0.95) 4.99 (6.22) .18
Prediabetes (HbA1c <48 mmol/mol)

All participants (n=27) 45.56 (1.49) 43.21 (2.39) 2.35 (1.96) 5.16 (4.31) <.001

Completers (n=18) 45.60 (1.43) 42.56 (2.38) 3.04 (1.82) 6.69 (4.01) <.001

Noncompleters (n=9) 45.48 (1.68) 44.51 (1.95) 0.97 (1.49) 2.11 (3.24) .09

aHbA1c: hemoglobin A1c.